Leveraging AI in Labeling

case-for-ICH-wp

From Regulatory Necessity to Strategic Advantage

AI in Labeling is emerging as an important milestone. After all, labeling has long been one of the most critical yet understated functions in life sciences. For years, its primary mandate was to ensure compliance, reflect approved data accurately and meet regulatory expectations across markets. The work was largely reactive, document-heavy and often siloed from broader development and commercialization conversations.

Increasingly complex products, faster development timelines, global regulatory convergence and more informed patients have made labeling a strategic, data-centric capability. At the heart of this evolution is AI in labeling, enabling organizations to use labeling to support the entire product lifecycle.

At Navitas Life Sciences, we see labeling transformation as a critical enabler of faster approvals, global alignment and clearer communication with healthcare professionals and patients. Artificial intelligence supports consistency and efficiency.

Why AI in Labeling Is Gaining Momentum Now

Several converging forces are accelerating AI adoption in labeling:

  • Increasing complexity of products, including cell and gene therapies, devices and combination products, and personalized medicines
  • Greater regulatory acceptance of digital submissions, structured content, and e-labeling
  • Rising expectations for patient-friendly, multilingual, and globally harmonized labeling
  • Pressure to reduce cycle times while maintaining inspection readiness

Traditional rule-based automation cannot keep pace with this complexity. AI-enabled labeling systems, by contrast, learn from data, adapt to change, and scale across products, regions and formats.

How AI Is Fundamentally Different from Traditional Automation

The journey to AI-enabled labeling did not happen overnight. In the early days, labeling relied heavily on manual processes and paper-based submissions. The introduction of digitization brought electronic documents and basic content management, followed by deeper automation and integration through RIM platforms. These advances improved efficiency and traceability, but they were still constrained by static rules and rigid workflows. As regulatory expectations expanded and products became more sophisticated, those limitations became increasingly apparent.

This is where artificial intelligence marks a true inflection point. Unlike traditional automation, which depends on predefined logic, AI systems learn from data and experience. Machine learning in regulatory operations allows systems to recognize patterns, identify inconsistencies, and adapt to change. Large language models in labeling can interpret complex regulatory and scientific text, while generative AI for regulatory labeling supports drafting, summarization, and comparison of content under appropriate human oversight. Together, these capabilities enable a more flexible, responsive approach to labeling—one that is better aligned with today’s regulatory and operational realities.

Core Types of AI Applications in Labeling

In real-world labeling environments, AI capabilities overlap and reinforce each

  • Analytical AI for document comparison, inconsistency detection and classification
  • Generative AI for drafting label text, summaries and patient-friendly language
  • Automation and machine learning for repetitive tasks, validations and workflow execution

These technologies support end-to-end labeling workflow optimization rather than isolated point solutions.

What makes AI particularly powerful in labeling is how different forms of AI work together. Analytical AI can surface discrepancies across documents and regions. Generative AI can propose revised language or summarize large volumes of source material. Automation and machine learning can then execute repetitive steps consistently and at scale. This convergence is what enables true labeling workflow optimization, moving beyond isolated efficiency gains to more connected, end-to-end processes.

High-Value, Appropriate Uses of AI in Labeling Today

Leading organizations are deploying AI selectively, focusing on use cases that deliver measurable value while remaining regulator-ready:

  • Document analysis and information retrieval across large labeling repositories
  • Automated labeling quality checks to detect gaps, misalignments, and outdated content
  • AI-assisted label authoring for first drafts and standard language development
  • AI for translation and localization, including cross-language consistency verification
  • Regulatory intelligence labeling to surface insights that support human decision-making
  • Labeling chatbots trained on SOPs to accelerate onboarding and knowledge access

Crucially, these applications position AI as a decision-support tool. In practice, organizations are applying AI thoughtfully, focusing first on use cases that deliver clear value while maintaining regulatory confidence. AI-assisted label authoring is helping teams accelerate first drafts and standard language development. Automated labeling quality checks are improving consistency by catching omissions and misalignments that manual review may miss. AI for translation and localization is supporting multilingual labeling, not only by generating draft translations but by verifying alignment between source and target text. Increasingly, AI is also being used for regulatory intelligence labeling, surfacing insights that support human decision-making rather than replacing it.

How Organizations Are Adopting AI in Practice

Despite strong interest, adoption remains pragmatic and phased. Many initiatives are still in pilot stages, with organizations prioritizing:

  • AI-assisted authoring and review
  • Translation and localization support
  • Regulatory and label intelligence
  • Submission data standards and conversion

More advanced, fully integrated implementations are progressing more gradually, reflecting the need for data readiness, system integration and change management.

Organizations that are seeing early success tend to start small and scale deliberately. They reuse approved regulatory responses, leverage structured templates and combine AI with existing translation memory approaches.

Navitas Life Sciences’ Perspective on AI in Labeling

From Navitas Life Sciences’ perspective, this is where many organizations need the most support. AI adoption in labeling is an operating model shift. Governance, validation, auditability and regulatory alignment must be designed in from the start.

Our approach focuses on helping organizations move confidently from experimentation to scale. By aligning AI enabled labeling initiatives with regulatory expectations, integrating them seamlessly into existing labeling and RIM ecosystems, and embedding strong oversight models, we help teams realize tangible benefits without compromising compliance or control.

AI is not replacing the judgment and expertise of labeling professionals but it is amplifying it. Organizations that embrace this shift thoughtfully will be better positioned to respond to change and communicate more effectively with regulators, healthcare professionals and patients alike.



To learn more about our services and solutions, please reach out to This email address is being protected from spambots. You need JavaScript enabled to view it..

Contract Research Organisation vs Clinical Researc...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us